Amendment 0004 Solicitation SPE2D2-24-R-0016(Bicalutamide) CANCELLED
Closed Solicitation Posted
- Solicitation number
- SPE2D2-24-R-0016
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical Supply Chain issued solicitation SPE2D2-24-R-0016 for a national requirements contract to procure Bicalutamide 50MG tablets in two bottle configurations: 30-count bottles (estimated 23,529 annually) and 500-count bottles (estimated 1,961 annually). The procurement was structured as an unrestricted, fully competitive acquisition for a firm-fixed price requirements contract with a one-year base period and four one-year option periods. The contract was intended to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers through DLA and VA prime vendor programs. The solicitation underwent multiple amendments extending the response deadline to February 14, 2025, and allowing email submissions due to systemic issues. However, Amendment 0004 ultimately cancelled the entire solicitation in its entirety on July 10, 2025.
This procurement utilized no set-aside designations, making it available to all qualified sources under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) with a size standard of 1,300 employees. The solicitation did not identify any incumbent contractors or specific award values, though it was structured as a commercial item procurement under FAR Part 12. The estimated annual quantities totaled approximately 25,490 units across both bottle configurations, with the larger 500-count bottles representing a significantly smaller volume requirement. Performance was designated for the United States, supporting federal healthcare systems through established prime vendor distribution networks. Despite the structured procurement approach and multiple deadline extensions to accommodate vendor participation, the solicitation was ultimately cancelled before award, leaving the pharmaceutical supply requirement unfulfilled through this particular contracting vehicle.
Notice text
3 versions
Update #3 · Latest ·
July 10,2024, Amendment 004 is hereby issued to cancel the subject solicitation in it's entirety
The Defense Logistics Agency is issue a solicitation for a national requirements contract for Bicalutamide 50MG tablets in bottle counts of 30 and 500. Procurement details follow.
DESCRIPTION EST QTY (YR)
Bicalutamide 50 MG Tablet – 30 Count 23,529
Bicalutamide 50 MG Tablet – 500 Count 1961
This is an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/
Interested parties should contact Keith Ryales (215-737-9199) (Keith. Ryales@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is TBA. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
NOTE:
\i) Amendment 0001 is Null and Void. Amendment 0001 has been deleted due to systemic issue, this amendment 0002 replaces 0001.
ii) The Revised Solicitation document is included / embedded in this file. Access the files(s) by following the instruction in order below:
Using Adobe Acrobat- 1. Go to thumbnail 2. Go to Attachments:(view files attached) (Attachments are under the Paperclip symbol)
THIS AMENDMENT INCLUDES THE FOLLOWNG: 1) Solicitation Closing Date is herein 02/07/2025 3:00 pm
2) Page 84 of 97 is has in revised
3) All other information in the original solicitation remains the same.
Update #2 ·
The Defense Logistics Agency is issue a solicitation for a national requirements contract for Bicalutamide 50MG tablets in bottle counts of 30 and 500. Procurement details follow.
DESCRIPTION EST QTY (YR)
Bicalutamide 50 MG Tablet – 30 Count 23,529
Bicalutamide 50 MG Tablet – 500 Count 1961
This is an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/
Interested parties should contact Keith Ryales (215-737-9199) (Keith. Ryales@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is TBA. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
NOTE:
\i) Amendment 0001 is Null and Void. Amendment 0001 has been deleted due to systemic issue, this amendment 0002 replaces 0001.
ii) The Revised Solicitation document is included / embedded in this file. Access the files(s) by following the instruction in order below:
Using Adobe Acrobat- 1. Go to thumbnail 2. Go to Attachments:(view files attached) (Attachments are under the Paperclip symbol)
THIS AMENDMENT INCLUDES THE FOLLOWNG: 1) Solicitation Closing Date is herein 02/07/2025 3:00 pm
2) Page 84 of 97 is has in revised
3) All other information in the original solicitation remains the same.
Update #1 ·
The Defense Logistics Agency is issue a solicitation for a national requirements contract for Bicalutamide 50MG tablets in bottle counts of 30 and 500. Procurement details follow.
DESCRIPTION EST QTY (YR)
Bicalutamide 50 MG Tablet – 30 Count 23,529
Bicalutamide 50 MG Tablet – 500 Count 1961
This is an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Department of Veterans Affairs, Indian Health Service and Bureau of Prisons customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and Sam.Gov at https://sam.gov/
Interested parties should contact Keith Ryales (215-737-9199) (Keith. Ryales@dla.mil) for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is TBA. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Files
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Solicitation | |
| Bicalutamide 50MG tablets | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity